Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_provenance.
- NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_assertion description "[The aim of the present study is to examine the relationship between dopamine D2-receptor gene (DRD2) polymorphisms (Taq1A, Taq1B, -141C Ins/Del) and the risk of extrapyramidal adverse effects (EPS), assessed according to the Drug-Induced Extra-Pyramidal Symptoms Scale (DIEPSS), or the maintenance dose of antipsychotics in schizophrenic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_provenance.
- NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_assertion evidence source_evidence_literature NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_provenance.
- NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_assertion SIO_000772 15966462 NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_provenance.
- NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_assertion wasDerivedFrom befree-20140225 NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_provenance.
- NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_assertion wasGeneratedBy ECO_0000203 NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP506745.RAsT3IegqVtvyKspzOcQS_1PkHnDZ-92L964MBbQ1EXkU130_provenance.